Urogen Pharma Ltd to Host UGN-102 Data Event Transcript
Good morning. Welcome, and thank you all for taking time to spend part of your morning with us. My name is Mark Schoenberg, I'm the Chief Medical Officer for UroGen Pharma. And we have a very exciting program for you today. So I'm glad you're here. This might be the only time anybody says in a venue like this, if you're not looking at your phone, please do so now. Two important press releases have just come out. So don't turn off your phones.
Anyway, these are our forward-looking statements. I won't read them to you. And this is our agenda for the morning. Our CEO, Liz Barrett, will come up to the podium in just a moment. We're going to have presentations by some scholars in the field as well as a very important data discussion and release. And then finally, a panel discussion and a Q&A. So we look forward to having a very interesting and robust conversation this morning about some very exciting data.
And with that, let me welcome Liz Barrett, CEO of UroGen to the podium.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
